165 related articles for article (PubMed ID: 33764848)
1. How can we assess and measure prognosis for MALT lymphoma? A review of current findings and strategies.
Kiesewetter B; Raderer M
Expert Rev Hematol; 2021 Apr; 14(4):391-399. PubMed ID: 33764848
[TBL] [Abstract][Full Text] [Related]
2. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.
Morgner A; Bayerdörffer E; Neubauer A; Stolte M
Gastroenterol Clin North Am; 2000 Sep; 29(3):593-607. PubMed ID: 11030075
[TBL] [Abstract][Full Text] [Related]
3. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
4. A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum β2-microglobulin levels.
Kim HD; Cho H; Jeong H; Bang K; Kim S; Lee K; Kang EH; Park JS; Park CS; Huh J; Ryu JS; Lee SW; Yoon DH; Oh SY; Suh C
Br J Haematol; 2021 Apr; 193(2):307-315. PubMed ID: 33216979
[TBL] [Abstract][Full Text] [Related]
5. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis.
Al-Taie O; Al-Taie E; Fischbach W
Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277
[TBL] [Abstract][Full Text] [Related]
6. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series.
Fischbach W; Goebeler ME; Ruskone-Fourmestraux A; Wündisch T; Neubauer A; Raderer M; Savio A;
Gut; 2007 Dec; 56(12):1685-7. PubMed ID: 17639089
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
Raderer M; Kiesewetter B; Ferreri AJ
CA Cancer J Clin; 2016; 66(2):153-71. PubMed ID: 26773441
[TBL] [Abstract][Full Text] [Related]
8. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in the oromaxillofacial head and neck region: A retrospective analysis of 105 patients.
Zhang T; Wu Y; Ju H; Meng J; Guo W; Ren G
Cancer Med; 2020 Jan; 9(1):194-203. PubMed ID: 31733094
[TBL] [Abstract][Full Text] [Related]
9. Early cancer of the stomach arising after successful treatment of gastric MALT lymphoma in patients with autoimmune disease.
Raderer M; Püspök A; Stummvoll G; Längle F; Chott A
Scand J Gastroenterol; 2003 Mar; 38(3):294-7. PubMed ID: 12737445
[TBL] [Abstract][Full Text] [Related]
10. [Marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type (MALT lymphoma)].
Takahashi T; Suzumiya J
Nihon Rinsho; 2014 Mar; 72(3):493-8. PubMed ID: 24724410
[TBL] [Abstract][Full Text] [Related]
11. [The clinical characteristics and prognostic analysis of gastric mucosa-associated lymphoid tissue lymphoma of 103 cases].
Li XW; Xia B; Guo Q; Jin X; Yu Y; Zhao ZG; Wang XF; Wang YF; Zhang YZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):805-9. PubMed ID: 23384898
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
13. A MALT lymphoma prognostic index.
Thieblemont C; Cascione L; Conconi A; Kiesewetter B; Raderer M; Gaidano G; Martelli M; Laszlo D; Coiffier B; Lopez Guillermo A; Torri V; Cavalli F; Johnson PW; Zucca E
Blood; 2017 Sep; 130(12):1409-1417. PubMed ID: 28720586
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
16. Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma.
Alderuccio JP; Reis IM; Habermann TM; Link BK; Thieblemont C; Conconi A; Larson MC; Cascione L; Zhao W; Cerhan JR; Zucca E; Lossos IS
Am J Hematol; 2022 Dec; 97(12):1529-1537. PubMed ID: 36057138
[TBL] [Abstract][Full Text] [Related]
17. Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development.
Sagaert X; Van Cutsem E; De Hertogh G; Geboes K; Tousseyn T
Nat Rev Gastroenterol Hepatol; 2010 Jun; 7(6):336-46. PubMed ID: 20440281
[TBL] [Abstract][Full Text] [Related]
18. Extranodal lymphoma of MALT-type: perspective at the beginning of the 21st century.
Raderer M; Isaacson PG
Expert Rev Anticancer Ther; 2001 Jun; 1(1):53-64. PubMed ID: 12113133
[TBL] [Abstract][Full Text] [Related]
19. Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.
Bacon CM; Du MQ; Dogan A
J Clin Pathol; 2007 Apr; 60(4):361-72. PubMed ID: 16950858
[TBL] [Abstract][Full Text] [Related]
20. MALT lymphomas: pathogenesis can drive treatment.
Bertoni F; Coiffier B; Salles G; Stathis A; Traverse-Glehen A; Thieblemont C; Zucca E
Oncology (Williston Park); 2011 Nov; 25(12):1134-42, 1147. PubMed ID: 22229204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]